Renaissance Technologies - SALARIUS PHARMACEUTICALS INC ownership

SALARIUS PHARMACEUTICALS INC's ticker is and the CUSIP is 79400X305. A total of 12 filers reported holding SALARIUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SALARIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16
-48.4%
24,142
+17.5%
0.00%
Q2 2023$31
-18.4%
20,542
+2.5%
0.00%
Q1 2023$38
+52.0%
20,042
+22.6%
0.00%
Q4 2022$2516,3420.00%
Other shareholders
SALARIUS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 225,000$148,0280.00%
Renaissance Technologies 24,142$160.00%
VANGUARD GROUP INC 14,263$9,3840.00%
HORIZON KINETICS ASSET MANAGEMENT LLC 32,400$21,3160.00%
UBS Group AG 78$510.00%
OSAIC HOLDINGS, INC. 1,387$9110.00%
FMR LLC 49$320.00%
BANK OF AMERICA CORP /DE/ 32$210.00%
WELLS FARGO & COMPANY/MN 27$180.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SALARIUS PHARMACEUTICALS INC shareholders